Haemangioblastoma

Haemangioblastomas are rare tumours that develop in the lining of blood vessels in the body. They most commonly develop in the central nervous system (CNS), which is composed of the brain and spinal cord, however they can also develop in other areas of the body, such as the kidneys, liver, and pancreas. While haemangioblastomas are generally benign, in rare cases they may become malignant.

The brain is a complex organ that is responsible for controlling all functions of the body. It has five main portions: the cerebrum, cerebellum, brainstem, pituitary gland, and hypothalamus. The cerebrum is the biggest part of the brain, and consists of the frontal, parietal, temporal, and occipital lobes. This part of the brain is responsible for voluntary movement, intelligence, and memory, and is often where glioblastomas develop. The cerebellum is a small part of the brain located at the back of the head, and regulates posture and balance. The brainstem is a small, stalk-like structure towards the bottom of the brain that connects the brain to the spinal cord.  It regulates many vital bodily processes, such as swallowing, breathing, and heart rate. The pituitary gland is a pea sized organ located behind the eyes, and is responsible for the production and secretion of hormones in the body. The hypothalamus is located deep within the brain, and has many important functions, such as producing and secreting different hormones, regulating temperature, and controlling appetite.

The spinal cord is a long, thin, tubular structure that extends down from the brainstem to the lower back. It is made of nerve tissue, and is surrounded by the bones of the spine (vertebrae). The spinal cord is responsible for transmitting nerve signals from the brain to the body, and vice versa. It has motor functions (such as voluntary movement), sensory functions (such as pressure, touch, temperature, and pain), and autonomous functions (such as regulating digestion, heart rate, and blood pressure).

Haemangioblastomas are often associated with Von Hippel-Lindau (VHL) syndrome, which is a rare genetic disorder that causes the development of multiple benign and malignant  tumour throughout the body.

Haemangioblastomas are slightly more common in males, and tend to develop between the ages of 30-60. However, anyone can develop this disease.

Treatment

When cancers are detected, they are staged and graded based on size, metastasis, and how the cancer cells look under the microscope. Staging and grading helps your doctors determine the best treatment for you. However, as the haemangioblastomas are considered benign, these tumours are generally considered low-grade and not staged.

Once your tumour has been diagnosed, your doctor may recommend genetic testing, which analyses your tumour DNA and can help determine which treatment has the greatest chance of success. They will then discuss the most appropriate treatment option for you.

Treatment is dependent on several factors, including location, age, stage of disease and overall health.

Treatment options for haemangioblastomas may include:

  • Watch and wait.
  • Surgery to remove as much of the tumour as possible.
  • Radiation therapy.
  • Antiangiogenic therapy.
  • Clinical trials.
  • Palliative care.

Risk factors

Because of how rare haemangioblastomas are, there has been limited research done into the risk factors of this disease. However, there has been a definitive link between the development of haemangioblastomas and patients who have been diagnosed with VHL.

Symptoms

Haemangioblastomas may appear asymptomatic during the early stages of disease. As the tumour progresses, some of the following symptoms may appear:

  • Hydrocephalus, which carries its own set of symptoms:
    • Headaches.
    • Nausea and/or vomiting.
    • Difficulties with eye movement.
    • Difficulties with balance.
    • Difficulties with walking.
  • Polycythaemia/erythrocytosis (high red blood cell concentration in the blood), which carries its own set of symptoms:
    • Headaches.
    • Blurred vision.
    • Red skin (especially in the face, hands, and feet).
    • Fatigue.
    • Hypertension.
    • Dizziness.
    • Abdominal discomfort and/or pain.
    • Confusion.
    • Bleeding problems, including nosebleeds and bruising.
    • Gout.
    • Itchy skin.
  • Difficulties with movement.
  • Back pain.
  • Numbness and/or tingling in the extremities.
  • Urinary incontinence.

Patients with VHL may experience additional symptoms depending on the tumours present.

Not everyone with the symptoms above will have cancer, but see your general practitioner (GP) if you are concerned.

Diagnosis

If your doctor suspects you have haemangioblastoma, they may order the following tests to confirm the diagnosis and refer you to a specialist for treatment:

  • Physical examination.
  • Neurological examination.
  • Imaging tests, potentially including:
    • MRI (magnetic resonance imaging).
    • CT (computed tomography) scan.
  • Blood tests.
  • Biopsy.

References

Keep up with Rare Cancers Australia

Inside Rare is a monthly newsletter that shares the latest news, events and stories connecting the rare community.